PUT - SPRINTER OPEN END - STRYKER CORP. Stock

Certificat

DE000VM55EL9

Delayed Deutsche Boerse AG 04:12:51 2024-05-20 am EDT
2.71 EUR -8.45% Intraday chart for PUT - SPRINTER OPEN END - STRYKER CORP.
Current month+13.41%
1 month+10.45%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-20 2.71 -8.45%
24-05-17 2.96 +3.14%
24-05-16 2.87 -7.42%
24-05-15 3.1 -19.48%
24-05-14 3.85 +2.67%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 04:12 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM55EL
ISINDE000VM55EL9
Date issued 2023-11-29
Strike 364.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 6.69
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.16
Lowest since issue 0.49
Spread 0.1
Spread %3.64%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.7 USD
Average target price
372.4 USD
Spread / Average Target
+11.26%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW